Clinical trial No longer in our active list Interventional Ages 18 and up

Optimizing pain management for a specific type of lung surgery

Official title: Optimization of Perioperative Analgesia Protocol for Uniportal Video-assisted Thoracoscopic Surgery: a Randomized Controlled Trial

Run by China-Japan Friendship Hospital · NCT06016777 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing which pain relief method works best for patients recovering from a specific type of lung surgery to help them feel better and heal faster.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment102 (estimated)
SponsorChina-Japan Friendship Hospital
Academic / other
Locations1 site (Beijing, Beijing)
Trial IDNCT06016777 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with early-stage lung cancer or those requiring intrathoracic tissue biopsy, who are suitable for elective uVATS.

Probably not a fit

Patients with severe comorbidities, chronic pain, or contraindications to the analgesic methods being tested may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to enhance postoperative pain management for patients undergoing uniportal video-assisted thoracoscopic surgery (uVATS). It is a single-blind randomized controlled study that will compare the effectiveness of three different analgesic techniques: thoracic paravertebral block, erector spinae block, and patient-controlled intravenous analgesia with sufentanil. A total of 102 patients will be enrolled and followed up at various intervals post-surgery to assess pain levels, ambulation time, and hospital stay duration. The study seeks to determine the optimal analgesic approach to improve recovery outcomes for these patients.

Why it matters

Potential benefit: If successful, this study could significantly reduce postoperative pain and improve recovery times for patients undergoing lung surgery.

How similar studies have gone: Previous studies have shown promising results with similar analgesic techniques in thoracic surgery, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. ≥18 years
2. ASA I-IIa
3. Early stage lung cancer or intrathoracic tissue biopsy, suitable for elective uVATSb
4. Informed consent obtained

Exclusion Criteria:

1. ASA≥III
2. History of intrathoracic or chest wall surgery
3. Chronic pain
4. Pre-operative analgesic medication use
5. NSAIDsc contraindications: aspirin asthma, allergic to NSAIDs, peptic ulcer, liver and kidney insufficiency, high risk of thrombotic events
6. Active autoimmune disease
7. Allergic to local anesthetics
8. Severe coagulation dysfunction, contraindicated for nerve block
9. Soft tissue infections of the chest wall

Where it's running

  • China-Japan Friendship Hospital
    Beijing, Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.